{"eventGroups":[{"deathsNumAffected":16,"deathsNumAtRisk":31,"description":"Participants meeting eligibility criteria and who underwent haploidentical stem cell transplantation with systemic chemotherapy and antibodies, including Fludarabine, Thioplex®, L-phenylalanine mustard, mycophenolate mofetil, CellCept®, Rituxan™, Muromonab (prior to January 2010) or Alemtuzumab (beginning January 2010), Cyclophosphamide, Anti-thymocyte globulin (Rabbit), and G-CSF.","id":"EG000","otherNumAffected":30,"otherNumAtRisk":31,"seriousNumAffected":20,"seriousNumAtRisk":31,"title":"High-Risk Hematologic Malignancies"}],"frequencyThreshold":"5","otherEvents":[{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":31,"numEvents":2}],"term":"Neutropenia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":31,"numEvents":8}],"term":"Hypertension"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":31,"numEvents":3}],"term":"Hypotension"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":31,"numEvents":4}],"term":"Mucositis"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":31,"numEvents":3}],"term":"Nausea (finding)"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":31,"numEvents":2}],"term":"Vomiting (disorder)"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":31,"numEvents":4}],"term":"Epistaxis"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":31,"numEvents":2}],"term":"Hemorrhagic cystitis"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":31,"numEvents":3}],"term":"Elevated ALT (SGPT)"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":31,"numEvents":3}],"term":"Elevated GGT"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":31,"numEvents":4}],"term":"Hyperglycemia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":31,"numEvents":7}],"term":"Hypokalemia (disorder)"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":31,"numEvents":2}],"term":"Hypophosphatemia (disorder)"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":31,"numEvents":2}],"term":"Confusion"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":31,"numEvents":2}],"term":"Encephalopathy"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":31,"numEvents":5}],"term":"Hypoxia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":31,"numEvents":2}],"term":"Acute renal failure"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":31,"numEvents":3}],"term":"Hemorrhagic cystitis"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","notes":"20 received Campath and were at risk","organSystem":"General disorders","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":10,"numAtRisk":20,"numEvents":10}],"term":"Cytokine Release Syndrome (Campath) [10/20 (50%)]"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","notes":"11 received muromonab and were at risk","organSystem":"General disorders","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":11,"numEvents":3}],"term":"Cytokine Release Syndrome (muromonab) [3/11 (27.27%)]"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":31,"numEvents":3}],"term":"Cytokine Release Syndrome (Stem Cell Infusion)"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":31,"numEvents":2}],"term":"Headache"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":31,"numEvents":2}],"term":"Pain, generalized, multiple sites"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":24,"numAtRisk":31,"numEvents":25}],"term":"Febrile neutropenia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":31,"numEvents":2}],"term":"Fever without neutropenia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":31,"numEvents":3}],"term":"Infection, adenovirus, blood"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":31,"numEvents":2}],"term":"Infection, adenovirus, respiratory tract"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":31,"numEvents":7}],"term":"Infection, adenovirus, stool"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":31,"numEvents":2}],"term":"Infection, BK Virus, bladder"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":31,"numEvents":9}],"term":"Infection, BK Virus, blood"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":31,"numEvents":8}],"term":"Infection, BK Virus, urine"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":31,"numEvents":5}],"term":"Infection, Clostridium Difficile, stool"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":31,"numEvents":2}],"term":"Infection, herpes simplex, lip"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":31,"numEvents":2}],"term":"Infection, Klebsiella pneumoniae, blood"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":31,"numEvents":4}],"term":"Infection, vancomycin-resistant enterococcus, rectum"}],"seriousEvents":[{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Immune system disorders","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":31,"numEvents":1}],"term":"Allergic reaction, micafungin"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":31,"numEvents":3}],"term":"Graft failure"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":31,"numEvents":1}],"term":"Coagulopathy"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":31,"numEvents":1}],"term":"Post-transplant lymphoproliferative disease"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":31,"numEvents":11}],"term":"Fever without neutropenia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":31,"numEvents":1}],"term":"Headache"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":31,"numEvents":1}],"term":"Rash"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":31,"numEvents":1}],"term":"Colitis"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":31,"numEvents":1}],"term":"Vomiting (disorder)"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":31,"numEvents":1}],"term":"Hemorrhage, diffuse alveolar"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Hepatobiliary disorders","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":31,"numEvents":1}],"term":"Failure, hepatic"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Hepatobiliary disorders","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":31,"numEvents":2}],"term":"Veno-occlusive disease, hepatic"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":31,"numEvents":2}],"term":"Encephalopathy"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":31,"numEvents":1}],"term":"Adult respiratory distress syndrome (disorder)"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":31,"numEvents":2}],"term":"Failure, renal"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":31,"numEvents":1}],"term":"Hemorrhagic cystitis"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":31,"numEvents":5}],"term":"Febrile neutropenia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":31,"numEvents":6}],"term":"Fever without neutropenia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":31,"numEvents":1}],"term":"Hepatitis"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":31,"numEvents":1}],"term":"Infection, acinetobacter baumannii, blood"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":31,"numEvents":2}],"term":"Infection, aceinetobacter calcoaceticus, baumannii, blood"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":31,"numEvents":1}],"term":"Infection, coagulase negative staphylocuccus, skin"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":31,"numEvents":1}],"term":"Infection, enterobacter cloacae, blood culture"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":31,"numEvents":1}],"term":"Infection, enterococcus faecalis, blood"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":31,"numEvents":1}],"term":"Infection, influenza type A, respiratory tract"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":31,"numEvents":4}],"term":"Infection, staphylocuccus epidermidis, blood"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":31,"numEvents":1}],"term":"Infection, urinary tract, gamma hemolytic streptococcus"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":31,"numEvents":1}],"term":"Infection, vancomycin-resistant enterococcus, blood"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"NCI CTC v. 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":31,"numEvents":1}],"term":"Infection, vancomycin resistant enterococcus, blood/Hickman line"}],"timeFrame":"Adverse events were collected from the date of participant enrollment through December 23, 2015."}